Rituximab improves the treatment results of DHAP-VIM-DHAP and ASCT in relapsed/progressive aggressive CD20+ NHL: a prospective randomized HOVON trial.

E. Vellenga; W.L.J. van Putten; M.B. van 't Veer; J.M. Zijlstra; W.E. Fibbe; M.H.J. van Oers; L.F. Verdonck; P.W. Wijermans; G.W. van Imhoff; P.J. Lugtenburg; P.C. Huijgens

Rituximab improves the treatment results of DHAP-VIM-DHAP and ASCT in relapsed/progressive aggressive CD20+ NHL: a prospective randomized HOVON trial.

Translated title of the contribution: Rituximab improves the treatment results of DHAP-VIM-DHAP and ASCT in relapsed/progressive aggressive CD20+ NHL: a prospective randomized HOVON trial.

E. Vellenga, W.L.J. van Putten, M.B. van 't Veer, J.M. Zijlstra, W.E. Fibbe, M.H.J. van Oers, L.F. Verdonck, P.W. Wijermans, G.W. van Imhoff, P.J. Lugtenburg, P.C. Huijgens

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Rituximab improves the treatment results of DHAP-VIM-DHAP and ASCT in relapsed/progressive aggressive CD20+ NHL: a prospective randomized HOVON trial.
Original language	Undefined/Unknown
Pages (from-to)	537-543
Number of pages	7
Journal	Blood
Volume	111
Issue number	2
Publication status	Published - 2008

Cite this

Vellenga, E., van Putten, W. L. J., van 't Veer, M. B., Zijlstra, J. M., Fibbe, W. E., van Oers, M. H. J., Verdonck, L. F., Wijermans, P. W., van Imhoff, G. W., Lugtenburg, P. J., & Huijgens, P. C. (2008). Rituximab improves the treatment results of DHAP-VIM-DHAP and ASCT in relapsed/progressive aggressive CD20+ NHL: a prospective randomized HOVON trial. Blood, 111(2), 537-543.

@article{61f72da4c5664f40987e9dafe381f036,

title = "Rituximab improves the treatment results of DHAP-VIM-DHAP and ASCT in relapsed/progressive aggressive CD20+ NHL: a prospective randomized HOVON trial.",

author = "E. Vellenga and {van Putten}, W.L.J. and {van 't Veer}, M.B. and J.M. Zijlstra and W.E. Fibbe and {van Oers}, M.H.J. and L.F. Verdonck and P.W. Wijermans and {van Imhoff}, G.W. and P.J. Lugtenburg and P.C. Huijgens",

year = "2008",

language = "Undefined/Unknown",

volume = "111",

pages = "537--543",

journal = "Blood",

issn = "0006-4971",

publisher = "Elsevier",

number = "2",

}

TY - JOUR

T1 - Rituximab improves the treatment results of DHAP-VIM-DHAP and ASCT in relapsed/progressive aggressive CD20+ NHL: a prospective randomized HOVON trial.

AU - Vellenga, E.

AU - van Putten, W.L.J.

AU - van 't Veer, M.B.

AU - Zijlstra, J.M.

AU - Fibbe, W.E.

AU - van Oers, M.H.J.

AU - Verdonck, L.F.

AU - Wijermans, P.W.

AU - van Imhoff, G.W.

AU - Lugtenburg, P.J.

AU - Huijgens, P.C.

PY - 2008

Y1 - 2008

M3 - Article

SN - 0006-4971

VL - 111

SP - 537

EP - 543

JO - Blood

JF - Blood

IS - 2

ER -